Zung Self-Rating Depression Scale: Free template

Key takeaways

The Zung Self-Rating Depression Scale is a 20-item self-report questionnaire developed by Dr. William W.K. Zung in 1965.

Patients rate each item on a 4-point scale, and the raw score of 20 to 80 converts to an SDS Index of 25 to 100.

Four severity bands read off that index: Normal below 50, mild 50 to 59, moderate 60 to 69, and severe from 70 up.

The 20 items cover affective, cognitive, and somatic symptoms, so the scale documents symptom burden rather than diagnosing depression.

Practice management software like Pabau lets patients complete the scale digitally, so the score is calculated and filed in the record automatically.

The Zung Self-Rating Depression Scale (SDS) is a clinician-facing screening tool that records depressive symptoms in a structured, validated format. Published in 1965, it remains one of the most widely used instruments in mental health, primary care, and psychology practice.

This page walks through the 20 items, the scoring formula, the cut-off thresholds, and where the scale is worth using in a caseload.

What is the Zung Self-Rating Depression Scale?

The Zung SDS is a 20-item self-report questionnaire that measures how severe a patient’s depressive symptoms are. Dr. William W.K. Zung developed it in 1965 as a brief, standardized measure clinicians could administer in routine practice. It has since been widely validated and used across mental health and primary care settings.

The scale measures three dimensions of depression. Affective items cover mood, motivation, and life satisfaction. Cognitive items cover decision-making, worthlessness, and outlook. Somatic items cover sleep, fatigue, and appetite changes.

Depression rarely arrives as a single emotional state. It shows up as a mix of emotional, cognitive, and physical changes, and the scale is built to pick up all three. That is also why it captures patient-reported severity in a form you can compare across visits. Psychology practice software can store those scores securely and show the trend across appointments.

The 20 items and what they measure

The scale presents 20 statements about emotional, cognitive, and physical experiences. Each one is rated on a 4-point scale, from never or rarely (1 point) to most or all of the time (4 points). The two middle options are sometimes (2 points) and good part of the time (3 points).

• Affective domain (5 items): depressed mood, crying spells, irritability, loss of interest, indecision
• Cognitive domain (5 items): self-blame, suicidal thoughts, emptiness, boredom, distractibility
• Somatic domain (10 items): sleep disturbance, fatigue, appetite changes, constipation, heart palpitations, dizziness, body aches, headaches, tremor, weight loss

Half the questionnaire is physical. That weighting reflects clinical evidence that bodily complaints often dominate how depression presents, particularly in older adults. It also holds in cultures where emotional symptoms are discussed less openly.

Patients can work through the 20 items on paper in the waiting room, or on a digital form before they arrive. A digital form scores itself, which takes the arithmetic out of the first few minutes of the appointment.

How to calculate the SDS Index

Scoring takes three steps: Add up the raw score, convert it to the SDS Index, and map the index to a severity band.

1. Sum raw scores: Add up the point values (1-4) assigned to each of the 20 items. The raw score ranges from 20 (minimum) to 80 (maximum).
2. Calculate the SDS Index: Use the formula SDS Index = (Raw Score ÷ 80) × 100. This puts every result on the same 25-100 scale, so you can compare across populations and time points.
3. Interpret severity: Map the SDS Index to one of four categories using published cut-off thresholds (see next section).

Example: A patient who scores 48 on the raw scale has an SDS Index of 60. That sits in the moderate range, which warrants clinical follow-up and a look at whether treatment needs stepping up.

The conversion is also where the scale’s floor catches people out. Because every item scores at least one point, the lowest possible result is an index of 25, not zero.

Interpreting scores and severity levels

The SDS Index maps to four severity categories. They guide the next clinical decision and give you plain language for explaining symptom burden to the patient.

Important caveat: Cut-off thresholds vary slightly across published studies and clinical populations. The ranges above represent the consensus from major validation studies. Apply clinical judgment alongside the score, and weigh cultural context, chronicity, and functional impact before you act on it.

Psychometric properties and validation evidence

The Zung SDS has been through extensive validation, and its psychometric properties support its use as a screening instrument.

• Internal consistency: Cronbach’s alpha ranges from 0.73 to 0.89 across studies, so the 20 items measure a single depression construct reliably.
• Sensitivity and specificity: The scale reaches 70-75% sensitivity and 70-80% specificity against clinical diagnosis of major depressive disorder. That is enough for screening, not for diagnosis.
• Test-retest reliability: Correlations of r = 0.80-0.91 show scores hold steady over 1-4 weeks when depressive status has not changed.
• Cross-cultural validity: The scale has been translated into more than 30 languages and validated across Asian, African, European, and South American populations.
• Responsiveness: The Zung SDS picks up clinically meaningful changes in severity after treatment, which is what makes it usable for monitoring.

Repeat administration is where those properties pay off. Scores collected the same way each time show whether symptoms are actually moving, which a clinical impression on its own cannot settle.

Where the scale fits in clinical practice

The Zung SDS does three jobs. It screens for undiagnosed depression, records baseline severity at the start of treatment, and tracks symptom change during care.

Screening: Mental health clinicians, primary care physicians, nurses, and physician assistants use it with patients who present with non-specific complaints. Fatigue, pain, and disrupted sleep are the common ones. An index of 50 or above prompts a fuller diagnostic evaluation.

Baseline assessment: Scored at the start of treatment, the scale fixes a reference point that later results are measured against. That makes the consent conversation about expected timelines concrete, and it gives you a treatment goal in a number.

Progress monitoring: Repeating the scale monthly or quarterly shows whether medication or therapy is reducing symptom burden. Scores that flatten or climb are the trigger to adjust treatment or refer on. Sharing the number with the patient turns it into a conversation about what changes next.

None of that works if the scores live in a paper folder. Most practices now keep them in software built for therapists, so any clinician seeing the patient can pull up the last three results in seconds.

How does the Zung SDS compare to other depression scales?

The Zung SDS is one of four instruments clinicians reach for. The others are the Patient Health Questionnaire (PHQ-9), the Beck Depression Inventory (BDI), and the Hamilton Rating Scale for Depression (HAM-D). Knowing what each one is good at makes the choice quicker.

Selection logic: Use the Zung SDS for routine screening and monitoring in primary care, general practice, and early mental health assessment. Reach for the shorter PHQ-9 template when speed matters and the workflow is already built around it.

Prefer the BDI-II or HAM-D when cognitive symptoms dominate, or when you are running psychotherapy research. Mental health EMR software that holds several instruments lets you pick the right one per patient and appointment type.

Known limitations of the scale

The Zung SDS is well validated, but it has limits that shape how far you can push a score.

• Screening, not diagnostic: A score points to probable depression and guides evaluation. It cannot stand in for a structured psychiatric interview, symptom duration, and functional impact.
• Cut-off variability: Published thresholds differ across studies and populations, particularly in non-Western samples. Use local validation data where it exists.
• Limited specificity for subtypes: The scale does not separate depression with anxiety, mixed features, psychosis, or bipolar depression. Anxious patients can score high on the somatic items alone.
• Cognitive demand: The 4-point response format needs intact cognition, so it can be hard going for patients with significant impairment, delirium, or dementia.
• Social desirability bias: Like every self-report measure, it invites underreporting to appear resilient, or overreporting to secure help. Consistent administration and rapport reduce both.

Clinical implication: Treat the Zung SDS as one part of a full mental health assessment, alongside the interview, functional history, and physical examination. Where anxiety symptoms dominate the picture, running the Zung anxiety scale alongside it helps separate the two symptom sets.

How Pabau handles depression screening and score tracking

On paper, the SDS costs more than the five minutes the patient spends on it. Someone adds up 20 numbers, writes the total into the notes, and files the sheet. The next clinician to see that patient has no quick way of telling whether the score has moved.

Practice management software like Pabau replaces that with a digital form the patient fills in before the appointment. The 20 items and the 4-point scale sit in the form builder. The raw total and the SDS Index calculate themselves, and the result lands in the client record.

Because the scores sit in the record, you can pull up a patient’s last three results during a review without hunting for paperwork. Repeat screening becomes a scheduled task rather than something to remember, and the client portal sends the form out ahead of the visit.

The outcome is a shorter appointment start and a cleaner record. You open the chart with the score already there, so the time goes on what the number means for this patient.

Run depression screening without the paperwork

Pabau captures Zung SDS responses digitally, calculates the SDS Index, and files the result in the client record. Your team can see every past score without opening a paper chart.

Book a demo

Conclusion

The Zung SDS earns its place because it is quick, free, and sensitive enough to surface depression a patient has not put into words. Use it to open the conversation and to measure what happens next, not to settle the question.

The trade-off is precision. An index of 62 tells you the burden is moderate. It does not tell you whether the cause is a depressive episode, an anxiety disorder with somatic symptoms, or an untreated thyroid problem. The clinical interview still decides that.

So score it the same way every time, repeat it on a schedule, and keep the results where the next clinician can find them. Book a demo to see how Pabau collects, scores, and stores depression screening across a whole caseload.

Continue your research

Comparing depression instruments before you commit to one? Beck Depression Inventory template covers the 21-item alternative used most in psychotherapy.

Need the shorter screener your primary care colleagues use? PHQ-9 and GAD-7 template pairs a 9-item depression screen with an anxiety measure.

Tracking mood between appointments? Daily mood chart gives patients a simple record to bring to the next session.

Did an item flag suicidal thoughts? Suicide safety plan sets out the steps to agree with a patient before they leave.

Documenting the full assessment? Psychiatric evaluation template structures history, mental status, and formulation in one document.

Frequently asked questions